(-0.67%) 5 073.50 points
(-0.56%) 38 464 points
(-1.04%) 17 480 points
(0.40%) $83.14
(-0.24%) $1.649
(0.07%) $2 340.10
(0.27%) $27.42
(-0.31%) $913.00
(-0.15%) $0.933
(-0.40%) $10.94
(-0.33%) $0.800
(-0.28%) $92.06
Live Chart Being Loaded With Signals
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis...
Stats | |
---|---|
Today's Volume | 2.78M |
Average Volume | 6.37M |
Market Cap | 8.18M |
EPS | $-0.0640 ( 2022-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.257 |
ATR14 | $0.131 (14.81%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-04-15 | Desparbes Eric | Buy | 231 693 | Common Stock |
2022-04-15 | Neumann Clarke | Buy | 184 843 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 2 transactions |
Buy: 416 536 | Sell: 0 |
Volume Correlation
Progenity, Inc. Correlation
10 Most Positive Correlations | |
---|---|
ALR | 0.96 |
HILS | 0.944 |
MBIN | 0.927 |
LFMDP | 0.924 |
RKDA | 0.915 |
SHIP | 0.906 |
TYRA | 0.904 |
WINT | 0.904 |
RELI | 0.903 |
VYNE | 0.902 |
10 Most Negative Correlations | |
---|---|
TBIO | -0.921 |
XPDI | -0.91 |
CCSI | -0.903 |
EYE | -0.898 |
WLTW | -0.897 |
PCAR | -0.896 |
ACHC | -0.882 |
JCOM | -0.868 |
ALHC | -0.863 |
FTXH | -0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Progenity, Inc. Correlation - Currency/Commodity
Progenity, Inc. Financials
Annual | 2023 |
Revenue: | $4 000.00 |
Gross Profit: | $-551 000 (-13 775.00 %) |
EPS: | $-7.87 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-117 000 (0.00 %) |
EPS: | $-0.620 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-125 000 (0.00 %) |
EPS: | $-4.89 |
Q2 | 2023 |
Revenue: | $2 000.00 |
Gross Profit: | $-164 000 (-8 200.00 %) |
EPS: | $-1.470 |
Financial Reports:
No articles found.
Progenity, Inc.
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company develops targeted oral delivery of biotherapeutics, including PGN-600, an orally delivered liquid formulation of tofacitinib for the treatment of ulcerative colitis; and PGN-001, an orally delivered variant of adalimumab for the treatment of ulcerative colitis. It also develops systemic oral delivery of biotherapeutics, which include PGN-OB, a combination product of a variant of adalimumab and the Oral Biotherapeutics Delivery System (OBDM) for the treatment of inflammatory conditions; and PGN-OB2, a combination product of a GLP-1 receptor agonist and the OBDS for the treatment of Type 2 diabetes. In addition, the company develops Recoverable Sampling System, an ingestible smart capsule designed to autonomously identify locations in the GI tract, collect, and preserve a sample for analysis; and PIL Dx, an ingestible smart capsule designed to sample, measure, and transmit results. It has partnership agreement with Ionis Pharmaceuticals to evaluate the OBDS for delivery of antisense oligonucleotides. The company was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators